Plus TherapeuticsCNSY
13F holders, Q2 2024 (June 30)12holders +2
4new positions
2sold out
1famous investor
$1.47avg. 13F price*
At the end of Q2 2024, 12 institutions reported holding Plus Therapeutics Inc. (CNSY) in their 13F filings, up 2 from Q1 2024. 4 opened new positions and 2 sold out. The largest holders were AIGH Capital Management LLC ($836K), Geode Capital Management, LLC ($69K) and Vanguard Group Inc. ($48K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Plus Therapeutics Inc.
- CUSIP
- 72941H509
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $842K |
| Exits | 2 | $31K |
All 13F filers, Q1 2024 → Q2 2024: 598,057 shares bought and 17,435 shares sold, net +580,622 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 12 holders
| AIGH Capital Management LLC | 0.41% | New | 568,681 | $836K |
| Geode Capital Management, LLC | 0.00% | Add +59.4% | 46,648 | $69K |
| Vanguard Group Inc. | 0.00% | No change | 32,541 | $48K |
| Citadel Advisors | 0.00% | Add +70.7% | 18,283 | $27K |
| BlackRock Inc. | 0.00% | No change | 6,960 | $10K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +9.3% | 4,186 | $6K |
| UBS Group AG | 0.00% | New | 3,199 | $5K |
| Ashton Thomas Private Wealth, LLC | 0.00% | New | 815 | $1K |
| Osaic Holdings, Inc. | 0.00% | No change | 133 | $195 |
| JPMorgan Chase & Co. | 0.00% | No change | 100 | $147 |
| Bank of America Corp. | 0.00% | New | 47 | $69 |
| Group One Trading LLC | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is CNSY's weight in each manager's 13F, not the share of Plus Therapeutics Inc. the manager owns.